Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in RadNet, Inc., Astrana Health or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how RadNet, Inc., Astrana Health and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About RadNet, Inc., Astrana Health and Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Latest Health Care Providers & Services and RadNet, Inc., Astrana Health, Inc. Stock News

As of July 31, 2026, RadNet, Inc. had a $5.0 billion market capitalization, compared to the Health Care Providers & Services median of $1.7 million. RadNet, Inc.’s stock is down 10.6% in 2026, up 3.6% in the previous five trading days and up 12.51% in the past year.

Currently, RadNet, Inc. does not have a price-earnings ratio. RadNet, Inc.’s trailing 12-month revenue is $2.1 billion with a -0.7% net profit margin. Year-over-year quarterly sales growth most recently was 22.1%. Analysts expect adjusted earnings to reach $0.516 per share for the current fiscal year. RadNet, Inc. does not currently pay a dividend.

As of July 31, 2026, Astrana Health, Inc. had a $1.6 billion market cap, putting it in the 51st percentile of all stocks. Astrana Health, Inc.’s stock is up 43.3% in 2026, down 11.8% in the previous five trading days and up 47.67% in the past year.

Currently, Astrana Health, Inc.’s price-earnings ratio is 58.4. Astrana Health, Inc.’s trailing 12-month revenue is $3.5 billion with a 0.9% net profit margin. Year-over-year quarterly sales growth most recently was 55.6%. Analysts expect adjusted earnings to reach $2.920 per share for the current fiscal year. Astrana Health, Inc. does not currently pay a dividend.

How We Compare RadNet, Inc., Astrana Health and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at RadNet, Inc., Astrana Health and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

RadNet, Inc., Astrana Health and Inc.’s Quality Grades

Company	Ticker	Quality
RadNet, Inc.	RDNT	D
Astrana Health, Inc.	ASTH	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

RadNet, Inc. has a Quality Score of 35, which is Weak. Astrana Health, Inc. has a Quality Score of 46, which is Average.

The Quality Stock Winner: No Clear Winner

Neither RadNet, Inc., Astrana Health or Inc. has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if RadNet, Inc., Astrana Health or Inc. is the better investment when it comes to quality.

RadNet, Inc., Astrana Health and Inc.’s Momentum Grades

Company	Ticker	Momentum
RadNet, Inc.	RDNT	B
Astrana Health, Inc.	ASTH	B

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

RadNet, Inc. has a Momentum Score of 64, which is Strong. Astrana Health, Inc. has a Momentum Score of 78, which is Strong.

The Momentum Grade Winner: It’s a Tie!

Looking at the Momentum Grade breakdown above, both RadNet, Inc., Astrana Health and Inc. have a grade of B. For those who focus solely on a company’s momentum, further research will need to be conducted into both companies to see if they fit your individual needs as an investor.

RadNet, Inc., Astrana Health and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
RadNet, Inc.	RDNT	D
Astrana Health, Inc.	ASTH	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

RadNet, Inc. has a Earnings Estimate Score of 26, which is Negative. Astrana Health, Inc. has a Earnings Estimate Score of 55, which is Neutral.

The Earnings Estimate Revisions Stock Winner: No Clear Winner

Neither RadNet, Inc., Astrana Health or Inc. has an Earnings Estimate Revisions Grade that could be considered a “winner.” Investors considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if RadNet, Inc., Astrana Health or Inc. is the better investment when it comes to estimate revisions.

Other RadNet, Inc., Astrana Health and Inc. Grades

In addition to Estimate Revisions, Quality and Momentum, A+ Investor also provides grades for Value and Growth.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether RadNet, Inc., Astrana Health and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, RadNet, Inc., Astrana Health or Inc. Stock?

Overall, RadNet, Inc. stock has a Momentum Score of 64, Estimate Revisions Score of 26 and Quality Score of 35.

Astrana Health, Inc. stock has a Momentum Score of 78, Estimate Revisions Score of 55 and Quality Score of 46.

Comparing RadNet, Inc., Astrana Health and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.